Does ELTROMBOPAG OLAMINE Cause Dyslipidaemia? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Dyslipidaemia have been filed in association with ELTROMBOPAG OLAMINE (ELTROMBOPAG). This represents 0.0% of all adverse event reports for ELTROMBOPAG OLAMINE.
5
Reports of Dyslipidaemia with ELTROMBOPAG OLAMINE
0.0%
of all ELTROMBOPAG OLAMINE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Dyslipidaemia From ELTROMBOPAG OLAMINE?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG OLAMINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG OLAMINE Cause?
Platelet count decreased (3,419)
Death (2,797)
Drug ineffective (1,117)
Platelet count increased (980)
Fatigue (868)
Headache (750)
Nausea (584)
Diarrhoea (558)
Product use in unapproved indication (545)
Malaise (516)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
Which ELTROMBOPAG OLAMINE Alternatives Have Lower Dyslipidaemia Risk?
ELTROMBOPAG OLAMINE vs ELUXADOLINE
ELTROMBOPAG OLAMINE vs ELVITEGRAVIR
ELTROMBOPAG OLAMINE vs EMAPALUMAB
ELTROMBOPAG OLAMINE vs EMAPALUMAB-LZSG
ELTROMBOPAG OLAMINE vs EMEND